-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Enanta Pharmaceuticals Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2023.
- Enanta Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $5.42M, a 22.6% decline year-over-year.
- Enanta Pharmaceuticals Inc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $25.8M, a 8.97% decline year-over-year.
- Enanta Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2023 was $28.2M, a 4.62% increase from 2022.
- Enanta Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2022 was $27M, a 28.5% increase from 2021.
- Enanta Pharmaceuticals Inc annual Share-based Payment Arrangement, Expense for 2021 was $21M, a 7.23% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)